☆ 4.7 Article

5-substituted 2-aminothiophenes as A1 adenosine receptor allosteric enhancers

BIOORGANIC & MEDICINAL CHEMISTRY (2008)

Journal

BIOORGANIC & MEDICINAL CHEMISTRY

Volume 16, Issue 3, Pages 1319-1327

Publisher

PERGAMON-ELSEVIER SCIENCE LTD

DOI: 10.1016/j.bmc.2007.10.065

Keywords

-

Categories

Biochemistry & Molecular Biology Chemistry, Medicinal Chemistry, Organic

Funding

NHLBI NIH HHS [R01HL56111] Funding Source: Medline

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Abstract

Two series of 5-substituted 2-amino-4-(3-trifluoromethylphenyl)thiophenes were prepared and evaluated as allosteric enhancers at the A(1) adenosine receptor (A(1)AR). In the 3-benzoyl series, a 5-phenyl group was found to confer the greatest potency (9a: ED50 = 2.1 mu M, AE score = 18%). However, the analogue with no 5-substituent (6b: ED50 = 15.8 mu M, AE score = 77%) proved to be the most efficacious. In the 3-ethoxycarbonyl series, the 5-(4-chlorophenyl) analogue was clearly the most potent and efficacious (91: ED50 = 6.6 mu M, AE score = 57%). The antagonist activity of all compounds was measured using a [H-3]CPX competitive binding assay. (c) 2007 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Review Endocrinology & Metabolism

Small molecule allosteric modulation of the adenosine A1 receptor

Anh T. N. Nguyen, Quan L. Tran, Jo-Anne Baltos, Samantha M. McNeill, Diep T. N. Nguyen, Lauren T. May

Summary: G protein-coupled receptors (GPCRs) are targeted by approximately one-third of FDA-approved small molecule drugs. Among the four adenosine GPCR subtypes, the adenosine A(1) receptor (A(1)R) plays important physiological roles in humans. A(1)R has been identified as a potential therapeutic target for various conditions, but the development of small molecule drugs targeting A(1)R has been limited by unwanted effects. An alternative approach using A(1)R allosteric modulators that target a different binding site shows promise in overcoming these limitations. This review provides insights into the therapeutic potential of A(1)R and recent advances in understanding its allosteric modulation.

FRONTIERS IN ENDOCRINOLOGY (2023)

Add to Collection

Article Chemistry, Medicinal

Optimization of 2-Amino-4,6-diarylpyrimidine-5-carbonitriles as Potent and Selective A1 Antagonists

Cristina Val, Carlos Rodriguez-Garcia, Ruben Prieto-Diaz, Abel Crespo, Jhonny Azuaje, Carlos Carbajales, Maria Majellaro, Alejandro Diaz-Holguin, Jose M. Brea, Maria Isabel Loza, Claudia Gioe-Gallo, Marialessandra Contino, Angela Stefanachi, Xerardo Garcia-Mera, Juan C. Estevez, Hugo Gutierrez-de-Teran, Eddy Sotelo

Summary: This study documents a large collection of 108 2-amino-4,6-disubstituted-pyrimidine derivatives as potent A(1)AR ligands, confirming their selectivity and structure-activity relationships. The study highlights the influence of aromatic residues at positions R-4 and R-6 of the pyrimidine core, as well as the role of a methyl group at the exocyclic amino group on A(1)AR selectivity profile.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Add to Collection

Article Chemistry, Applied

Access to 5-Substituted 3-Aminofuran/Thiophene-2-Carboxylates from Bifunctional Alkynenitriles

Chandresh Kumari, Avijit Goswami

Summary: An atom-economical approach for the synthesis of 3-aminofurans/thiophenes via conjugate addition and modified Thorpe-Ziegler cyclization has been reported. This operationally simple method offers a rapid access to a diverse library of compounds.

ADVANCED SYNTHESIS & CATALYSIS (2022)

Add to Collection

Article Chemistry, Medicinal

Examining the Role of the Linker in Bitopic N6-Substituted Adenosine Derivatives Acting as Biased Adenosine A1 Receptor Agonists

Jon Kyle Awalt, Anh T. N. Nguyen, Tim J. Fyfe, Bui San Thai, Paul J. White, Arthur Christopoulos, Manuela Joerg, Lauren T. May, Peter J. Scammells

Summary: The adenosine A(1) receptor is a therapeutic target for cardioprotection during myocardial ischemia and reperfusion injury. However, clinical translation of A(1)R agonists is hindered by dose-limiting adverse effects. The bitopic agonist VCP746, consisting of an adenosine pharmacophore linked to an allosteric moiety, has shown promising results in stimulating cardioprotective A(1)R signaling effects without unwanted bradycardia. This study investigates the structure-activity relationships of VCP746 and identifies the most potent A2BR agonist to date.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Synthesis of 2-chloropurine ribosides with chiral amino acid amides at C6 and their evaluation as A1 adenosine receptor agonists

Maria Ya Berzina, Barbara Z. Eletskaya, Alexei L. Kayushin, Elena Dorofeeva, Olga Lutonina, Ilya Fateev, Alexander S. Paramonov, Maria A. Kostromina, Evgeniy A. Zayats, Yulia A. Abramchik, Dmitriy Maltsev, Ludmila Naumenko, Alena S. Taran, Dmitry S. Yakovlev, Alexander A. Spasov, Anatoly Miroshnikov, Roman S. Esipov, Irina D. Konstantinova

Summary: A series of purine ribonucleosides with chiral amino acid amides were synthesized and their affinity for A(1) adenosine receptors (A(1)ARs) was investigated. It was found that some of the synthesized nucleosides exhibited partial agonist activity towards A(1)ARs and showed different profiles of psychoactive action and ocular hypotensive effect.

BIOORGANIC CHEMISTRY (2022)

Add to Collection

Article Pharmacology & Pharmacy

An allosteric modulator of the adenosine A1 receptor potentiates the antilipolytic effect in rat adipose tissue

Kequan Fu, Wenbing Chen, Mingzhu Meng, Huimin Zhao, Haoxing Yuan, Yinan Wang, Ying Ren, Yi Yun, Dong Guo

Summary: The adenosine A1 receptor is an important target for metabolic disorders and plays a significant role in regulating free fatty acid levels. This study examined the effect of an allosteric modulator on the action of an A1 receptor agonist in regulating lipolysis. The results showed that the allosteric modulator enhanced the antilipolytic action of the agonist by slowing down its dissociation from the receptor and downregulating the cAMP/HSL pathway. This study highlights the potential application of A1 receptor allosteric modulators in the treatment of metabolic diseases.

EUROPEAN JOURNAL OF PHARMACOLOGY (2023)

Add to Collection

Review Biochemistry & Molecular Biology

The Signaling Pathways Involved in the Anticonvulsive Effects of the Adenosine A1 Receptor

Jeroen Spanoghe, Lars E. Larsen, Erine Craey, Simona Manzella, Annelies Van Dycke, Paul Boon, Robrecht Raedt

Summary: Activation of adenosine A(1) receptor can inhibit seizures through various signaling pathways leading to neuronal inhibition. However, chronic activation of the A(1) receptor may have detrimental effects that should be avoided in the development of epilepsy therapies based on this receptor.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Pharmacology & Pharmacy

Investigation of adenosine A1 receptor-mediated β-arrestin 2 recruitment using a split-luciferase assay

Luisa Saecker, Hanns Haeberlein, Sebastian Franken

Summary: In this study, a live cell assay for A(1)AR-mediated beta-arrestin 2 recruitment was characterized. The assay showed that Capadenoson exhibited partial agonism in beta-arrestin 2 recruitment, but full agonism in the inhibitory effect on cAMP production. Furthermore, it was demonstrated for the first time that a valerian extract can stimulate A(1)AR-mediated beta-arrestin 2 recruitment.

FRONTIERS IN PHARMACOLOGY (2023)

Add to Collection

Article Chemistry, Multidisciplinary

Convergent synthesis of 2-thioether-substituted (N)-methanocarba-adenosines as purine receptor agonists

R. Rama Suresh, Russell B. Poe, Baorui Lin, Kexin Lv, Ryan G. Campbell, Zhan-Guo Gao, Theodore E. Liston, Kiran S. Toti, Kenneth A. Jacobson

Summary: A linear route is used to prepare (N)-methanocarba-nucleoside derivatives with a pre-established receptor-preferred conformation, which bind to receptors after functional group modifications. The method provides moderate to good yield by introducing a rigid ribose substitute and conserving key intermediate 3 in nine sequential steps. The general applicability of this convergent synthesis for various substituents demonstrates its efficacy as an optimized preclinical synthetic route.

RSC ADVANCES (2021)

Add to Collection

Article Biology

Allosteric modulation of the adenosine A2A receptor by cholesterol

Shuya Kate Huang, Omar Almurad, Reizel J. Pejana, Zachary A. Morrison, Aditya Pandey, Louis-Philippe Picard, Mark Nitz, Adnan Sljoka, R. Scott Prosser

Summary: Cholesterol indirectly modulates the conformational equilibria and signaling of the adenosine A(2A) receptor by influencing membrane properties.

ELIFE (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Characterization and Seasonal Modulation of Adenosine A1 Receptors in the Arctic Ground Squirrel Brain

Zachary Carlson, Kelly Drew

Summary: Hibernation is an adaptation that allows animals to survive without food or water. Understanding the mechanisms of metabolic suppression during hibernation could lead to new treatments in critical care. The activation of Adenosine A(1) receptor (A(1)AR) plays a role in hibernation, but its role in seasonal sensitization is unknown. In this study, the A(1)AR in different brain regions of Arctic ground squirrels during summer and torpor seasons was characterized, and the pharmacological characteristics of A(1)AR agonist and antagonist were defined.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Novel positive allosteric modulators of A2B adenosine receptor acting as bone mineralisation promoters

Elisabetta Barresi, Chiara Giacomelli, Laura Marchetti, Emma Baglini, Silvia Salerno, Giovanni Greco, Federico Settimo, Claudia Martini, Maria Letizia Trincavelli, Sabrina Taliani

Summary: The study investigated compounds with chemical similarity to known PAMs of A(2B) AR, identifying lead compounds with potential as anti-osteoporosis agents. Further characterization of benzofurane derivative 9 confirmed its role as a PAM of A(2B) AR.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)

Add to Collection

Article Medicine, Research & Experimental

Paris saponin H inhibits the proliferation of glioma cells through the A1 and A3 adenosine receptor-mediated pathway

Linlin Bi, Yang Liu, Qian Yang, Xuanxuan Zhou, Hua Li, Jie Li, Yunyang Lu, Haielng Tang

Summary: The study investigated the effects of Paris saponin H (PSH) on U251 glioblastoma cells and found that PSH inhibited cell viability, migration, invasion, induced apoptosis, and cell cycle arrest by inhibiting ARA1 and ARA3 expression, repressing Akt and 44/42 MAPK phosphorylation.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2021)

Add to Collection

Article Pharmacology & Pharmacy

Evaluation of adenosine A1 receptor agonists as neuroprotective countermeasures against Soman intoxication in rats

Kristy L. Meads, Thaddeus P. Thomas, Jeffrey L. Langston, Todd M. Myers, Tsung-Ming Shih

Summary: The study found that A1AR agonists can provide neuroprotection and prevent cognitive and behavioral deficits caused by soman poisoning. The use of an active avoidance shuttle box task showed that animals treated with A1AR agonists exhibited more avoidance responses and a faster reaction to aversive stimuli compared to the soman/saline control group.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2021)

Add to Collection

Article Endocrinology & Metabolism

Feeding desensitizes A1 adenosine receptors in adipose through FOXO1-mediated transcriptional regulation

Mitchell E. Granade, Stefan R. Hargett, Daniel S. Lank, Michael C. Lemke, Melissa A. Luse, Brant E. Isakson, Irina M. Bochkis, Joel Linden, Thurl E. Harris

Summary: Adipose tissue response to adenosine changes dynamically according to nutrient conditions through the insulin-Akt-FOXO1 axis. Deletion of adipocyte A1R leads to impairments in lipolysis suppression by insulin under fasting conditions and compromised glucose tolerance. Refeeding results in downregulation of A1R transcription and desensitization of adipocytes to A1R agonism, facilitating reentrance into the catabolic state upon fasting.

MOLECULAR METABOLISM (2022)

Add to Collection

Article Chemistry, Medicinal

4-Phenylpyridin-2-one Derivatives: A Novel Class of Positive Allosteric Modulator of the M1 Muscarinic Acetylcholine Receptor

Shailesh N. Mistry, Manuela Joerg, Herman Lim, Natalie B. Vinh, Patrick M. Sexton, Ben Capuano, Arthur Christopoulos, J. Robert Lane, Peter J. Scammells

JOURNAL OF MEDICINAL CHEMISTRY (2016)

Add to Collection

Article Biochemistry & Molecular Biology

Novel Fused Arylpyrimidinone Based Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor

Shailesh N. Mistry, Herman Lim, Manuela Joerg, Ben Capuano, Arthur Christopoulos, J. Robert Lane, Peter J. Scammells

ACS CHEMICAL NEUROSCIENCE (2016)

Add to Collection

Article Chemistry, Multidisciplinary

Utility of iron nanoparticles and a solution-phase iron species for the N-demethylation of alkaloids

Jon Kyle Awalt, Raymond Lam, Barrie Kellam, Bim Graham, Peter J. Scammells, Robert D. Singer

GREEN CHEMISTRY (2017)

Add to Collection

Article Medicine, Research & Experimental

Ionic Liquid Forms of Weakly Acidic Drugs in Oral Lipid Formulations: Preparation, Characterization, in Vitro Digestion, and in Vivo Absorption Studies

Yasemin Sahbaz, Tri-Hung Nguyen, Leigh Ford, Claire L. McEvoy, Hywel D. Williams, Peter J. Scammells, Christopher J. H. Porter

MOLECULAR PHARMACEUTICS (2017)

Add to Collection

Article Chemistry, Multidisciplinary

Zwitterionic Modification of Ultrasmall Iron Oxide Nanoparticles for Reduced Protein Corona Formation

Karina Pombo-Garcia, Carmen L. Ruehl, Raymond Lam, Jose A. Barreto, Ching-Seng Ang, Peter J. Scammells, Peter Comba, Leone Spiccia, Bim Graham, Tanmaya Joshi, Holger Stephan

CHEMPLUSCHEM (2017)

Add to Collection

Article Pharmacology & Pharmacy

The structural determinants of the bitopic binding mode of a negative allosteric modulator of the dopamine D-2 receptor

Christopher J. Draper-Joyce, Mayako Michino, Ravi Kumar Verma, Carmen Klein Herenbrink, Jeremy Shonberg, Anitha Kopinathan, Peter J. Scammells, Ben Capuano, David M. Thal, Jonathan A. Javitch, Arthur Christopoulos, Lei Shi, J. Robert Lane

BIOCHEMICAL PHARMACOLOGY (2018)

Add to Collection

Article Chemistry, Medicinal

Fluorescently Labeled Morphine Derivatives for Bioimaging Studies

Raymond Lam, Arisbel B. Gondin, Meritxell Canals, Barrie Kellam, Stephen J. Briddon, Bim Graham, Peter J. Scammells

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Add to Collection

Article Chemistry, Medicinal

A Structure-Activity Relationship Study of Bitopic N6-Substituted Adenosine Derivatives as Biased Adenosine A1 Receptor Agonists

Luigi Aurelio, Jo-Anne Baltos, Leigh Ford, Anh T. N. Nguyen, Manuela Jorg, Shane M. Devine, Celine Valant, Paul J. White, Arthur Christopoulos, Lauren T. May, Peter J. Scanunells

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Add to Collection

Article Chemistry, Medicinal

Synthesis and Pharmacological Evaluation of Heterocyclic Carboxamides: Positive Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor with Weak Agonist Activity and Diverse Modulatory Profiles

Juliana C. C. Dallagnol, Elham Khajehali, Emma T. van der Westhuizen, Manuela Jorg, Celine Valant, Alan G. Goncalves, Ben Capuano, Arthur Christopoulos, Peter J. Scammells

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Add to Collection

Article Chemistry, Medicinal

Transformation of Biopharmaceutical Classification System Class I and III Drugs Into Ionic Liquids and Lipophilic Salts for Enhanced Developability Using Lipid Formulations

Hywel D. Williams, Leigh Ford, Shea Lim, Sifei Han, John Baumann, Hannah Sullivan, David Vodak, Annabel Igonin, Hassan Benameur, Colin W. Pouton, Peter J. Scammells, Christopher J. H. Porter

JOURNAL OF PHARMACEUTICAL SCIENCES (2018)

Add to Collection

Article Pharmacology & Pharmacy

Assessment of the Molecular Mechanisms of Action of Novel 4-Phenylpyridine-2-One and 6-Phenylpyrimidin-4-One Allosteric Modulators at the M-1 Muscarinic Acetylcholine Receptors

Emma T. van der Westhuizen, Arthur Spathis, Elham Khajehali, Manuela Jorg, Shailesh N. Mistry, Ben Capuano, Andrew B. Tobin, Patrick M. Sexton, Peter J. Scammells, Celine Valant, Arthur Christopoulos

MOLECULAR PHARMACOLOGY (2018)

Add to Collection

Article Multidisciplinary Sciences

The action of a negative allosteric modulator at the dopamine D2 receptor is dependent upon sodium ions

Christopher J. Draper-Joyce, Ravi Kumar Verma, Mayako Michino, Jeremy Shonberg, Anitha Kopinathan, Carmen Klein Herenbrink, Peter J. Scammells, Ben Capuano, Ara M. Abramyan, David M. Thal, Jonathan A. Javitch, Arthur Christopoulos, Lei Shi, J. Robert Lane

SCIENTIFIC REPORTS (2018)

Add to Collection

Article Chemistry, Medicinal

Synthesis and Pharmacological Evaluation of Noscapine-Inspired 5-Substituted Tetrahydroisoquinolines as Cytotoxic Agents

Shane M. Devine, Cassandra Yong, Dzifa Amenuvegbe, Luigi Aurelio, Divya Muthiah, Colin Pouton, Richard Callaghan, Ben Capuano, Peter J. Scammells

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Add to Collection

Article Medicine, Research & Experimental

Enhancing the Oral Absorption of Kinase Inhibitors Using Lipophilic Salts and Lipid-Based Formulations

Hywel D. Williams, Leigh Ford, Sifei Han, Kristian J. Tangso, Shea Lim, David M. Shackleford, David T. Vodak, Hassan Benameur, Colin W. Pouton, Peter J. Scammells, Christopher J. H. Porter

MOLECULAR PHARMACEUTICS (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Structure of the Adenosine A1 Receptor Reveals the Basis for Subtype Selectivity

Alisa Glukhova, David M. Thal, Anh T. Nguyen, Elizabeth A. Vecchio, Manuela Jorg, Peter J. Scammells, Lauren T. May, Patrick M. Sexton, Arthur Christopoulos

CELL (2017)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.